Hedeker Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-36,313
Closed -$2.29M 76
2021
Q1
$2.29M Buy
36,313
+548
+2% +$34.1K 0.8% 48
2020
Q4
$2.22M Buy
35,765
+153
+0.4% +$9.41K 0.78% 47
2020
Q3
$2.15M Sell
35,612
-16,257
-31% -$978K 1.02% 43
2020
Q2
$3.05M Sell
51,869
-7,405
-12% -$443K 1.57% 29
2020
Q1
$3.3M Buy
59,274
+32,342
+120% +$1.98M 2.08% 18
2019
Q4
$1.73M Sell
26,932
-433
-2% -$24.8K 0.93% 44
2019
Q3
$1.39M Buy
27,365
+299
+1% +$14.1K 0.84% 45
2019
Q2
$1.23M Buy
27,066
+3,230
+14% +$150K 0.78% 44
2019
Q1
$1.21M Buy
23,836
+3,798
+19% +$189K 0.91% 42
2018
Q4
$1.04M Sell
20,038
-2,011
-9% -$108K 0.84% 43
2018
Q3
$1.37M Sell
22,049
-756
-3% -$44.9K 0.96% 41
2018
Q2
$1.26M Sell
22,805
-1,254
-5% -$67.7K 0.97% 41
2018
Q1
$1.52M Buy
24,059
+96
+0.4% +$6.18K 1.18% 39
2017
Q4
$1.47M Sell
23,963
-541
-2% -$33.8K 1.14% 42
2017
Q3
$1.56M Buy
24,504
+5,508
+29% +$322K 1.37% 38
2017
Q2
$1.06M Buy
18,996
+468
+3% +$25.5K 1.02% 46
2017
Q1
$1.01M Sell
18,528
-1,677
-8% -$92K 0.95% 47
2016
Q4
$1.18M Buy
20,205
+18,860
+1,402% +$1.03M 0.97% 43
2016
Q3
$24.9K Sell
1,345
-13,966
-91% -$897K 1.29% 25
2016
Q2
$1.13M Buy
15,311
+12,075
+373% +$853K 0.98% 39
2016
Q1
$206K Sell
3,236
-3,236
-50% -$204K 0.19% 77
2015
Q4
$445K Hold
6,472
0.39% 57
2015
Q3
$383K Buy
+6,472
New +$411K 0.33% 79

Other funds holding BMY

Hedeker Wealth's BMY Position: Q2 2021 in Review

Hedeker Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 36,313 shares — an estimated $2.29M sold.

Hedeker Wealth first reported a position in BMY in Q3 2015 and held it in 23 quarters. The position peaked at $3.3M in Q1 2020. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Hedeker Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Hedeker Wealth sold 36,313 Bristol-Myers Squibb shares in Q2 2021, an estimated $2.29M.
  • Hedeker Wealth first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 23 quarters.
  • Hedeker Wealth's Bristol-Myers Squibb position peaked at $3.3M in Q1 2020.
  • 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Hedeker Wealth's 13F filing for Q2 2021, filed 21 Jul 2021.